Cours Lonza Group Ltd Other OTC
Actions
LZAGY
US54338V1017
Recherche biotechnologique et médicale
CA 2024 * | 6,64 Md 7,26 Md | CA 2025 * | 7,44 Md 8,13 Md | Capitalisation | 38,06 Md 41,58 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 904 M 988 M | Résultat net 2025 * | 1,11 Md 1,22 Md | VE / CA 2024 * | 6,06 x |
Dette nette 2024 * | 2,18 Md 2,38 Md | Dette nette 2025 * | 2,47 Md 2,7 Md | VE / CA 2025 * | 5,44 x |
PER 2024 * |
42,7
x | PER 2025 * |
34,2
x | Employés | - |
Rendement 2024 * |
0,85% | Rendement 2025 * |
0,98% | Flottant | 95,87% |
Dernier transcript sur Lonza Group Ltd
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/04/17 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01/12/21 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01/08/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16/04/14 |
Director/Board Member | 66 | 16/04/14 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05/05/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51% | 42,75 Md | |
+8,57% | 41,34 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md | |
-16,98% | 10,07 Md |